| JVMRX | RVACX | JVMRX / RVACX | |
| Total Expense Ratio | 0.74 | 2.07 | 36% |
| Annual Report Gross Expense Ratio | 0.75 | 3.21 | 23% |
| Fund Existence | 15 years | 19 years | - |
| Gain YTD | 8.922 | 5.699 | 157% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000000 | 2500 | 40,000% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 22.9B | 250M | 9,160% |
| Annual Yield % from dividends | 0.81 | 0.14 | 566% |
| Returns for 1 year | 8.08 | 1.07 | 752% |
| Returns for 3 years | 21.91 | -0.13 | -16,394% |
| Returns for 5 years | 11.43 | -17.57 | -65% |
| Returns for 10 years | 65.14 | -24.32 | -268% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| BBP | 91.63 | 1.62 | +1.80% |
| Virtus LifeSci Biotech Products ETF | |||
| OPTZ | 49.36 | 0.62 | +1.26% |
| Optimize Strategy Index ETF | |||
| EUFN | 39.10 | 0.37 | +0.96% |
| iShares MSCI Europe Financials ETF | |||
| ABLD | 30.24 | -0.02 | -0.05% |
| Abacus FCF Real Assets Leaders ETF | |||
| FGDL | 55.84 | -0.30 | -0.53% |
| Franklin Responsibly Sourced Gold ETF | |||